It was previously reported that pharmacological inhibition of MPO by 4-aminobenzoic acid hydrazide reduces plaque formation in the mouse apolipoprotein E knockout (ApoE−/−) model of atherosclerosis [66]. The gene discussed is MPO; the disease is atherosclerosis.